Shaikhibrahim, Z., & Duensing, S. (2014). MED12 overexpression is a frequent event in castration-resistant prostate cancer. Endocrine related cancer, 21(4), . https://doi.org/10.1530/ERC-14-0171
Chicago-Zitierstil (17. Ausg.)Shaikhibrahim, Zaki, und Stefan Duensing. "MED12 Overexpression Is a Frequent Event in Castration-resistant Prostate Cancer." Endocrine Related Cancer 21, no. 4 (2014). https://doi.org/10.1530/ERC-14-0171.
MLA-Zitierstil (9. Ausg.)Shaikhibrahim, Zaki, und Stefan Duensing. "MED12 Overexpression Is a Frequent Event in Castration-resistant Prostate Cancer." Endocrine Related Cancer, vol. 21, no. 4, 2014, https://doi.org/10.1530/ERC-14-0171.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.